Etiology and Factors Affecting Severe Complications and Mortality of Febrile Neutropenia in Children with Acute Leukemia
暂无分享,去创建一个
H. Ören | N. Belet | Ş. Yılmaz | Ö. Tüfekçi | C. Özlü | Ayşe Çakıl Güzin | Şilem Özdem Alataş | I. Erbaş | H. Karaoğlu Asrak | Şefika Akyol | İlknur Akansu | Canan Özlü
[1] A. Groll,et al. 8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation. , 2021, The Lancet. Oncology.
[2] R. Seth,et al. Outcomes of Febrile Neutropenia in Children With Cancer Managed on an Outpatient Basis: A Report From Tertiary Care Hospital From a Resource-limited Setting , 2020, Journal of pediatric hematology/oncology.
[3] M. Bhatia,et al. Microbiological Profile of Blood Stream Infections in Febrile Neutropenic Patients at a Tertiary Care Teaching Hospital in Rishikesh, Uttarakhand , 2020, Journal of Laboratory Physicians.
[4] G. Gabutti,et al. Viral Respiratory Infections in Hematological Patients , 2020, Infectious Diseases and Therapy.
[5] A. Simon,et al. Management of children with fever and neutropenia: results of a survey in 51 pediatric cancer centers in Germany, Austria, and Switzerland , 2020, Infection.
[6] Han Xiao,et al. Risk Prediction and Prognosis of Invasive Fungal Disease in Hematological Malignancies Patients Complicated with Bloodstream Infections , 2020, Cancer management and research.
[7] S. Kabra,et al. Prevalence and clinical outcome of respiratory viral infections among children with cancer and febrile neutropenia , 2019, Pediatric hematology and oncology.
[8] R. Dessein,et al. Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor. , 2019, The Journal of infection.
[9] K. Yu,et al. Clinical risk score for invasive fungal diseases in patients with hematological malignancies undergoing chemotherapy: China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study , 2019, Frontiers of Medicine.
[10] Hande Kızılocak,et al. Febrile Neutropenia in Children with Cancer: Approach to Diagnosis and Treatment. , 2018, Current pediatric reviews.
[11] A. Trehan,et al. Risk Factors for Microbiologically-documented Infections, Mortality and Prolonged Hospital Stay in Children with Febrile Neutropenia , 2018, Indian Pediatrics.
[12] R. Ammann,et al. Pediatric patients at risk for fever in chemotherapy-induced neutropenia in Bern, Switzerland, 1993-2012 , 2018, Scientific Data.
[13] Jae Wook Lee,et al. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study , 2017, BMC Infectious Diseases.
[14] A. Trehan,et al. Can complications in febrile neutropenia be predicted? Report from a developing country , 2017, Supportive Care in Cancer.
[15] S. Alexander,et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Jae Wook Lee,et al. Increase in Antibiotic-Resistant Gram-Negative Bacterial Infections in Febrile Neutropenic Children , 2016, Infection & chemotherapy.
[17] J. Albert,et al. Frequent Respiratory Viral Infections in Children with Febrile Neutropenia - A Prospective Follow-Up Study , 2016, PloS one.
[18] He Huang,et al. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[19] J. Carratalá,et al. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours. , 2014, Journal of Infection.
[20] C. Viscoli,et al. Prophylaxis and Empirical Therapy of Infection in Cancer Patients , 2014, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases.
[21] E. Trecarichi,et al. Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact , 2014, Current opinion in infectious diseases.
[22] F. Shann,et al. Antibiotic-resistant Gram-negative Bacteremia in Pediatric Oncology Patients—Risk Factors and Outcomes , 2013, The Pediatric infectious disease journal.
[23] A. Srinivasan,et al. Prospective Detection of Respiratory Pathogens in Symptomatic Children With Cancer , 2012, The Pediatric infectious disease journal.
[24] S. Alexander,et al. Updated Systematic Review and Meta-Analysis of the Performance of Risk Prediction Rules in Children and Young People with Febrile Neutropenia , 2012, PloS one.
[25] M. Kim,et al. Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections , 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[26] M. Kvezereli-Kopadze,et al. [Neutropenia in children]. , 2011, Georgian medical news.
[27] Clsi. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement , 2010 .
[28] J. Corral,et al. Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia. , 2010, Current oncology.
[29] D. Catchpoole,et al. Respiratory viruses, a common microbiological finding in neutropenic children with fever , 2010, Journal of Clinical Virology.
[30] D. Srivastava,et al. Etiology and Clinical Course of Febrile Neutropenia in Children With Cancer , 2009, Journal of pediatric hematology/oncology.
[31] O. Ruuskanen,et al. Respiratory Viral Infections in Children With Leukemia , 2008, The Pediatric infectious disease journal.
[32] B. Lund,et al. Febrile neutropenia in children with cancer: A retrospective Norwegian multicentre study of clinical and microbiological outcome , 2008, Scandinavian journal of infectious diseases.
[33] H. Ören,et al. ASSESSMENT OF FEBRILE NEUTROPENIA EPISODES IN CHILDREN WITH ACUTE LEUKEMIA TREATED WITH BFM PROTOCOLS , 2008, Pediatric hematology and oncology.
[34] C. Leone,et al. Procalcitonin (PCT) and C-reactive Protein (CRP) as severe systemic infection markers in febrile neutropenic adults , 2007, BMC infectious diseases.
[35] C. Viscoli,et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] M. Paesmans,et al. Bacteraemia in febrile neutropenic cancer patients. , 2007, International journal of antimicrobial agents.
[37] G. Lyman,et al. Length of stay and mortality associated with febrile neutropenia among children with cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] C. Viscoli,et al. Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] H. Ariffin,et al. SURVEILLANCE STUDY OF BACTERAEMIC EPISODES IN FEBRILE NEUTROPENIC CHILDREN , 2002, International journal of clinical practice.
[40] M. O'Ryan,et al. Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] L. Elting,et al. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[42] C. Mullen,et al. Early hospital discharge of children with cancer treated for fever and neutropenia: identification and management of the low-risk patient. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[43] K. Sepkowitz,et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[44] F. Marco,et al. Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000 , 2004, Annals of Hematology.